Money recovered, accused arrested — What’s happening in the IDFC First Bank Rs 590 crore scam case? Top developments

Haryana’s State Vigilance and Anti-Corruption Bureau has arrested four people in connection with the Rs 590 crore fraud involving IDFC First Bank, officials said on Wednesday. Those arrested include two former bank employees and two private individuals who operate a partnership firm. The arrests were made late Tuesday as the investigation gathered pace.This follows the…

Read More

Gold price prediction today: Will gold, silver be able to hold on to gains this week? Here’s the outlook

Positive outlook persists for precious metals for medium to long terms. (AI image) Gold price prediction today: Gold prices are moving up but the lack of any major positive catalyst may limit the upside this week, says Maneesh Sharma, AVP – Commodities & Currencies, Anand Rathi Shares and Stock Brokers.Bullions prices started the current week…

Read More

‘Drill, baby, drill’: Donald Trump hails US oil boost, calls Venezuela ‘new friend and partner’

US President Donald Trump on Tuesday (local time) reiterated his “drill, baby, drill” push for the country, as he highlighted rising energy outputs. Addressing the 2026 State of the Union, he went on to describe Venezuela as America’s new “friend and partner.” Trump said, “American natural gas production is at an all-time high because I…

Read More

Asian stocks today: Markets trade in green after Wall Steet’s strong rally; Nikkei jumps over 2% to record highs

Asian stocks traded in green on Wednesday, mirroring Wall Street’s gains and sustained enthusiasm around the artificial intelligence boom. Investors also kept close eye on US President Donald Trump’s State of the Union address, delivered during Asian trading hours. In Japan, Nikkei benchmark index touched a fresh record, leading the positive mood across the region.Nikkei…

Read More

Your weight-loss drugs set to become cheaper

NEW DELHI: The country’s anti-obesity market is headed for a pricing shake-up, with a clutch of pharma companies readying plans to launch affordable versions of the blockbuster weight-loss medicines Wegovy and Ozempic. This follows the expiry of the patent of semaglutide, the key ingredient in these injectable medications, on March 20, clearing the entry of…

Read More